Diagnostic and therapeutic challenges for patients with ANCA-associated vasculitides at the time of COVID-19. Response to: ‘Rituximab for granulomatosis with polyangiitis in the pandemic of COVID-19: lessons from a case with severe pneumonia’ by Guilpain et alComment Published on 2021-01-012023-07-14 Journal: Annals of the rheumatic diseases [Category] SARS, [키워드] Autoimmunity rituximab systemic vasculitis [DOI] 10.1136/annrheumdis-2020-217555 [Article Type] Comment
Rituximab Use in Warm and Cold Autoimmune Hemolytic AnemiaReview Published on 2020-12-132024-09-02 Journal: Journal of Clinical Medicine [Category] 대상포진, [키워드] autoimmune hemolytic anemia treatment Cold agglutinin disease rituximab warm autoimmune hemolytic anemia [DOI] 10.3390/jcm9124034 PMC 바로가기 [Article Type] Review
High rates of severe disease and death due to SARS-CoV-2 infection in rheumatic disease patients treated with rituximab: a descriptive studyObservational Study Published on 2020-12-012023-07-13 Journal: Rheumatology International [Category] SARS, [키워드] COVID-19 Rheumatic diseases rituximab SARS-CoV-2 [DOI] 10.1007/s00296-020-04699-x PMC 바로가기 [Article Type] Observational Study
Prospektive Verlaufsbeobachtung einer universitären Rheumaambulanzkohorte während der ersten Welle der COVID-19-Pandemie Welche Lehren kann man ziehen?Originalien Published on 2020-11-302022-10-28 Journal: Zeitschrift Fur Rheumatologie [Category] COVID-19, MERS, SARS, [키워드] COVID-19 COVID-19 pandemic COVID-19-Pandemie flare Immunosuppressive medication Immunsuppressive Therapie initial Isar material Region Rheumaerkrankung rheumatic disease rituximab SARS-CoV-2 SLE Therapieadjustierung Treatment adjustment [DOI] 10.1007/s00393-020-00935-8 PMC 바로가기 [Article Type] Originalien
Simultaneous disseminated infections with intracellular pathogens: an intriguing case report of adult-onset immunodeficiency with anti-interferon-gamma autoantibodies세포내 병원체에 의한 동시 분산 감염: 항 인터페론 감마 자가항체를 가진 성인 발병 면역 결핍의 흥미로운 사례 보고Case Report Published on 2020-11-112024-07-29 Journal: BMC Infectious Diseases [Category] 살모넬라증, [키워드] cytomegalovirus interferon gamma Interferon gamma autoantibodies interleukin 12 Non-tuberculous mycobacteria Non-typhoidal Salmonella rituximab [DOI] 10.1186/s12879-020-05553-y PMC 바로가기 [Article Type] Case Report
Evaluation of the rate of COVID-19 infection, hospitalization and death among Iranian patients with multiple sclerosis이란 다발성 경화증 환자의 코로나19 감염, 입원, 사망 비율 평가Article Published on 2020-11-012022-09-12 Journal: Multiple sclerosis and related disorders [Category] SARS, 진단, [키워드] addition asked clinic Complication Computed tomography Contact correlation COVID-19 COVID-19 diagnosis COVID-19 infection COVID-19 symptoms COVID19 death demographic characteristics Diagnosis died disease drug evaluate evaluated General population highlight Hospitalization immunosuppressive drug incidence of COVID-19 increase increasingly lung medication Multiple multiple sclerosis Nurse Patient patients PCR polymerase chain positive rate of infection risk risk reduction rituximab severity of COVID-19 social distancing the disease these symptom Two patient underlying disease was performed were infected were recorded [DOI] 10.1016/j.msard.2020.102472 PMC 바로가기 [Article Type] Article
Evaluating the perspective of patients with MS and related conditions on their DMT in relation to the COVID-19 pandemic in one MS centre in Australia호주의 한 MS 센터에서 COVID-19 전염병과 관련하여 DMT에 대한 MS 및 관련 상태 환자의 관점 평가Article Published on 2020-11-012022-09-12 Journal: Multiple sclerosis and related disorders [Category] SARS, 진단, [키워드] anti-CD20 therapy Anxiety B-cell benefit Cohort condition conducted COVID-19 COVID-19 pandemic cross-sectional depleting disease disorder evaluate Evaluating Express Factor Government had no immunomodulatory immunosuppressive in both groups increased risk information majority Mild moderate Multiple multiple sclerosis Natalizumab Ocrelizumab outcome pandemic Patient Perspective Precaution proportion provided receiving resource risk rituximab sclerosis severe disease Symptom theoretical risk Therapies therapy Treatment worsening [DOI] 10.1016/j.msard.2020.102516 PMC 바로가기 [Article Type] Article
COVID-19 and the Brain: Acute Encephalitis as a Clinical ManifestationInternal Medicine Published on 2020-10-032022-10-31 Journal: Cureus [Category] COVID-19, [키워드] Acute delirium acute encephalopathy Altered mental status clinical CNS Coma Confusion Coronavirus disease 2019 COVID-19 disease Encephalitis Encephalopathy hallmark increasingly Intravenous immunoglobulin manifestation Meningitis Mild Most patient nervous system Patient Respiratory system rituximab syndrome Treatment viral encephalitis viral infection [DOI] 10.7759/cureus.10784 PMC 바로가기 [Article Type] Internal Medicine
Severe COVID-19 virus reactivation following treatment for B cell acute lymphoblastic leukemiaLetter to the Editor Published on 2020-10-022022-10-29 Journal: Journal of Hematology & Oncology [Category] COVID-19, MERS, SARS, [키워드] antibodies Antibody titer anticoagulation appear B cell characteristic Chest CT convalescent plasma COVID-19 COVID-19 virus cytarabine discharge discharged home female Frame ground-glass opacity Hospitalized immunosuppressive Infection inflammatory markers intensive care leukemia lymphocyte lymphopenia nasal New York City oxygen PCR PCR positivity polymerase chain positive question raise Reactivation receiving recovered COVID-19 patient Reinfection risk rituximab SARS-CoV-2 Severe COVID-19 pneumonia Steroids Swab therapy transfer Treatment unlikely viral reactivation with COVID-19 [DOI] 10.1186/s13045-020-00968-1 PMC 바로가기 [Article Type] Letter to the Editor
COVID-19: Infection or AutoimmunityImmunology Published on 2020-09-112022-11-01 Journal: Frontiers in Immunology [Category] COVID-19, MERS, SARS, [키워드] anti-CD20 therapy asymptomatic state Autoimmune autoimmune disorder Autoimmunity Basic science clinical presentation COVID-19 depleting Efficacy explain hemophagocytic lymphohistiocytosis immunomodulating immunopathology Immunosuppression immunosuppressive laboratory feature manifestation medication MIS-C myocarditis pathophysiology Pneumonia recent regimen Research reveal review rituximab syndrome T cell the disease therapy thymoglobulin Variation variety [DOI] 10.3389/fimmu.2020.02055 PMC 바로가기 [Article Type] Immunology